Analysis of Influencing Factors of Compliance with Non-Vitamin K Antagonist Oral Anticoagulant in Patients with Nonvalvular Atrial Fibrillation and Correlation with the Severity of Ischemic Stroke

Table 5

Comparison of clinical end points between the two groups (n, %).

Group	Ischemic stroke	Hemorrhagic events
Good compliance group (n = 59)	3 (5.1)	6 (10.2)
Poor compliance group (n = 87)	15 (17.2)	10 (11.5)
χ^2	4.807	0.063
	0.028	0.801